IL10 and neoplasm: Besides being involved in T cell education, several studies also reported on downregulation of MHC class II expression on antigen-presenting cells (APCs) and of MHC class I on tumor cells in cancer patients with elevated IL-10 levels in serum or tumors (12–18).